Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kerstin Borgmann

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Toxicology|November 6, 2003
Molecular mechanisms of individual radiosensitivity studied in normal diploid human fibroblastsEkkehard Dikomey, Kerstin Borgmann, Ingo Brammer, et al.
Radiation and Environmental Biophysics|February 27, 2009
Sex-specific aspects of tumor therapyKerstin Borgmann, Ekkehard Dikomey, Cordula Petersen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 14, 2012
DNA damage by X-rays and their impact on replication processesAnn Christin Parplys, Eva Petermann, Cordula Petersen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 15, 2006
Lymphoblastoid cell lines differing in p53 status show clear differences in basal gene expression with minor changes after irradiationOliver Zschenker, Kerstin Borgmann, Thomas Streichert, et al.
Cancers|October 13, 2021
Beyond the Double-Strand Breaks: The Role of DNA Repair Proteins in Cancer Stem-Cell RegulationJacqueline Nathansen, Felix Meyer, Luise Müller, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 15, 2007
Genetic determination of chromosomal radiosensitivities in G0- and G2-phase human lymphocytesKerstin Borgmann, Doris Haeberle, Thilo Doerk, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2004
For X-irradiated normal human fibroblasts, only half of cell inactivation results from chromosomal damageKerstin Borgmann, Mirco Dede, Agnieszka Wrona, et al.
Deutsches Arzteblatt International|May 24, 2021
Late Sequelae of Radiotherapy—The Effect of Technical and Conceptual Innovations in Radiation OncologyUlrike Hoeller, Kerstin Borgmann, Michael Oertel, et al.
Cancers|July 2, 2020
The Intermediate Filament Synemin Regulates Non-Homologous End Joining in an ATM-Dependent MannerSara Sofia Deville, Anne Vehlow, Sarah Förster, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 24, 2023
DNA as the main target in radiotherapy-a historical overview from first isolation to anti-tumour immune responseBenjamin Frey, Kerstin Borgmann, Tina Jost, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Toxicology|November 6, 2003
Molecular mechanisms of individual radiosensitivity studied in normal diploid human fibroblastsEkkehard Dikomey, Kerstin Borgmann, Ingo Brammer, et al.
Radiation and Environmental Biophysics|February 27, 2009
Sex-specific aspects of tumor therapyKerstin Borgmann, Ekkehard Dikomey, Cordula Petersen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 14, 2012
DNA damage by X-rays and their impact on replication processesAnn Christin Parplys, Eva Petermann, Cordula Petersen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 15, 2006
Lymphoblastoid cell lines differing in p53 status show clear differences in basal gene expression with minor changes after irradiationOliver Zschenker, Kerstin Borgmann, Thomas Streichert, et al.
Cancers|October 13, 2021
Beyond the Double-Strand Breaks: The Role of DNA Repair Proteins in Cancer Stem-Cell RegulationJacqueline Nathansen, Felix Meyer, Luise Müller, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 15, 2007
Genetic determination of chromosomal radiosensitivities in G0- and G2-phase human lymphocytesKerstin Borgmann, Doris Haeberle, Thilo Doerk, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2004
For X-irradiated normal human fibroblasts, only half of cell inactivation results from chromosomal damageKerstin Borgmann, Mirco Dede, Agnieszka Wrona, et al.
Deutsches Arzteblatt International|May 24, 2021
Late Sequelae of Radiotherapy—The Effect of Technical and Conceptual Innovations in Radiation OncologyUlrike Hoeller, Kerstin Borgmann, Michael Oertel, et al.
Cancers|July 2, 2020
The Intermediate Filament Synemin Regulates Non-Homologous End Joining in an ATM-Dependent MannerSara Sofia Deville, Anne Vehlow, Sarah Förster, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 24, 2023
DNA as the main target in radiotherapy-a historical overview from first isolation to anti-tumour immune responseBenjamin Frey, Kerstin Borgmann, Tina Jost, et al.
Pageof 9